How to Account for R&D Tax Credits: ASC 740, Form 6765, and Section 174

Accounting for the federal R&D tax credit splits into two paths depending on what the credit offsets. If it reduces income tax, you account for it under ASC 740, typically using the flow-through method: the benefit flows through income tax expense in the year the credit arises. If a qualified small business elects to apply the credit against the employer share of Social Security tax, the credit sits outside ASC 740 and is recorded as a reduction of payroll tax expense (or as other income) instead. The calculation on Form 6765, the Section 280C election, and the Section 174 treatment of the underlying costs all feed the numbers you eventually book.

Income Tax Credit Under ASC 740

When the credit offsets income tax, U.S. GAAP puts it inside ASC 740. Two methods are acceptable, the flow-through method and the deferral method, and the flow-through method is the common choice for research credits. It treats the full benefit as a reduction to income tax expense in the year the credit arises.

The journal entry depends on whether the credit is used currently or carried forward. If the credit reduces taxes payable in the current year, debit income tax expense and credit income taxes payable. If the company cannot absorb the full credit this year and carries it forward, the entry creates a deferred tax asset instead: debit deferred tax asset, credit income tax expense. Either way, the credit lowers the effective tax rate on the income statement.

Valuation Allowance on Carryforward Assets

A deferred tax asset for a credit carryforward is only worth carrying at full value if the company expects to generate enough future taxable income to use it. If that expectation is not strong enough, a valuation allowance offsets the asset and neutralizes the benefit on the balance sheet until circumstances change. The assessment looks at projected income, the remaining carryforward period, and whether the company has a track record of taxable income. Loss-heavy companies frequently record a full or partial valuation allowance against R&D credit carryforwards for exactly this reason.

Uncertain Tax Positions

R&D credit claims are among the most frequently examined items on a corporate return, so the uncertain tax position analysis under ASC 740 matters here more than for most credits. A company cannot recognize a tax benefit in its financial statements unless the position is more likely than not to be sustained on examination based purely on its technical merits. The analysis assumes the IRS examines the position with full knowledge of all relevant facts and that any dispute goes to the highest court.

If the position clears that threshold, the benefit is measured at the largest dollar amount with a greater than 50 percent likelihood of being realized upon settlement. If a $2 million credit claim has a 70 percent chance of being sustained at $1.5 million but only a 40 percent chance at $2 million, you record $1.5 million. The gap between the amount claimed on the return and the amount recognized in the financial statements is the reserve, and it must be disclosed.

Payroll Tax Credit Accounting

Startups and young companies that do not yet owe income tax can elect to apply the credit against the employer share of Social Security taxes. The election is available to a “qualified small business,” meaning gross receipts under $5 million in the current year and no gross receipts at all before the five-year period ending with the current tax year.¹ The maximum payroll credit election in a single year is $500,000.²

The election is made on Form 6765 filed with the original, timely filed income tax return (including extensions). The credit does not become available against payroll taxes until the first calendar quarter that begins after the income tax return is filed. A calendar-year company that files its 2025 return in March 2026 first uses the payroll credit on the Form 941 for the second quarter of 2026. Form 8974 is attached to each Form 941 (or Form 943 or 944) to actually apply the credit against the payroll tax liability.³

Because this credit reduces Social Security tax rather than income tax, it falls outside ASC 740. No single authoritative GAAP standard explicitly governs how business entities account for government assistance of this kind. In practice, companies look to the government grant model under IAS 20 or the contributions framework in ASC 958-605 by analogy. Under either approach, the credit is recorded as a reduction to payroll tax expense or as other income rather than as a reduction to the income tax provision. The journal entry debits the payroll tax liability account and credits the corresponding expense or income line. For a pre-profit company with substantial wages and little or no income tax, the effect on cash is immediate.

Calculating the Credit Amount

The credit is incremental: it rewards growth in research spending above a baseline rather than granting a flat percentage of total R&D costs. The choice of calculation method is made on Form 6765.

Regular Credit

The regular credit equals 20 percent of the amount by which current-year qualified research expenses exceed a base amount. The base amount is a fixed-base percentage multiplied by the average of the four prior years’ gross receipts. For established companies, the fixed-base percentage comes from the ratio of R&D spending to gross receipts during 1984 through 1988. Companies that did not exist then use a start-up formula that phases in over ten years.⁴ The base amount can never be less than 50 percent of current-year qualified research expenses.⁵

Alternative Simplified Credit

The alternative simplified credit is 14 percent of the amount by which current-year qualified research expenses exceed 50 percent of the average qualified research expenses over the three preceding tax years. If the company had no qualified research expenses in any of those three prior years, the rate drops to 6 percent of total current-year expenses with no base subtraction. Many companies prefer this method because it avoids the historical 1984–1988 data requirement.⁵

To reach a credit amount, the company still has to identify qualifying activities under the Section 41 four-part test and pull out the qualifying wages, supplies, and contract research (the last at 65 percent of amounts paid).¹ Those inputs are outside the scope of the accounting question but they set the ceiling on what can be booked.

The Section 280C Election

You cannot both deduct the R&D expenses in full and claim a credit on the same dollars. Under Section 280C, you either reduce the R&D deduction by the full credit amount or elect a reduced credit that avoids any deduction adjustment. Electing the reduced credit drops the regular rate from 20 percent to 15.8 percent, and the alternative simplified credit is multiplied by 79 percent. The election is made directly on Form 6765 and applies for the entire tax year.⁴ Most C corporations elect the reduced credit at the 21 percent tax rate, but the right choice depends on the specific tax profile. Whatever you choose, the election drives the credit number that flows into the ASC 740 journal entry.

Carryforward and Carryback

The R&D credit is a component of the general business credit under Section 38, so it shares the general business credit carryover rules. Unused credit carries back one year and then forward up to twenty years.⁶

Ordering matters when multiple general business credits are in play. Carryforwards from prior years are applied first, then current-year credits, then carrybacks. Within the current-year pool, the R&D credit is the fourth component applied, behind the investment credit, work opportunity credit, and alcohol fuels credit.⁷ Every credit dollar carried forward creates a deferred tax asset that has to be tested for realizability under ASC 740, and a company that consistently generates more credit than it can use will likely need a valuation allowance.

How Section 174 Affects the Numbers

The tax treatment of the underlying R&D spending feeds directly into the credit calculation, and that treatment has changed twice in the last few years.

Starting with tax years beginning in 2022, the Tax Cuts and Jobs Act eliminated immediate deduction of research and experimental expenditures. Companies had to capitalize those costs and amortize them over five years for domestic research or fifteen years for foreign research. The amortization uses a mid-year convention, defined as the first day of the seventh month, which produces a first-year deduction of only 10 percent of the capitalized amount for a full twelve-month year.⁸ The result was a near-term increase in taxable income even when actual spending had not changed, and a corresponding shift in deferred tax accounting.

In 2025, Congress restored immediate expensing for domestic research expenditures. Companies can now fully deduct domestic R&D costs in the year incurred. Those that capitalized domestic costs from 2022 through 2024 can elect to recover the remaining unamortized balances either entirely in 2025 or split equally between 2025 and 2026. Foreign research expenditures still require 15-year amortization. Because the Section 174 classification of a cost feeds the four-part test that determines what qualifies for the credit, the tax treatment of the expense and the credit calculation cannot be kept in separate boxes.

Financial Statement Disclosures

Footnotes should explain the nature of the research activities claimed, the methodology used to identify qualifying expenses, the total credit recognized in the period, and any carryforward balance available for future use. Disclose the Section 280C election and its effect on the reported numbers. Where significant management judgment is involved, such as the probability of the IRS sustaining a claim on examination, the assumptions and the potential financial impact of a different outcome need to be disclosed.

Corporations with total assets of $10 million or more must file Schedule UTP (Uncertain Tax Position Statement) with Form 1120 if they have recorded a reserve for an uncertain tax position in the current year or any prior year. R&D credits frequently trigger this requirement because the four-part test and the expense allocation involve enough judgment that companies routinely reserve a portion of the claimed benefit. The schedule asks for a concise description of the tax position and the relevant code section but does not require disclosure of the dollar amount reserved.⁹

Filing the Credit on Form 6765

The credit is claimed by attaching Form 6765 to the income tax return: Form 1120 for C corporations, Form 1065 for partnerships, Form 1120-S for S corporations. The elections between regular and alternative simplified credit, and the Section 280C election, must be made on Form 6765 filed with the original, timely filed return (including extensions).⁴ Partners and S corporation shareholders generally do not file Form 6765 themselves; they report their share of the credit on Form 3800, the general business credit form.¹⁰

Section G Business Component Reporting

For tax years beginning after 2025, Form 6765 adds a required Section G that breaks down qualified research expenses by individual business component. You must report enough components to cover at least 80 percent of total qualified research expenses, up to a maximum of 50 components. Each component requires detail on wages for direct research, supervision, and support, along with supply costs, computer rental costs, and contract research amounts. For tax years beginning before 2026 this reporting was optional; starting with the 2026 return it is mandatory.⁴ Companies that have not tracked expenses at the project level will need to rebuild their cost-allocation processes before filing, because the accounting entry ultimately has to tie back to numbers the form can support.

1
Office of the Law Revision Counsel. 26 U.S. Code 41 – Credit for Increasing Research Activities
2
Internal Revenue Service. Qualified Small Business Payroll Tax Credit for Increasing Research Activities
3
Internal Revenue Service. Instructions for Form 8974
4
Internal Revenue Service. Instructions for Form 6765 (Rev. December 2025)
5
Office of the Law Revision Counsel. 26 USC 41 – Credit for Increasing Research Activities
6
Office of the Law Revision Counsel. 26 U.S. Code 39 – Carryback and Carryforward of Unused Credits
7
Office of the Law Revision Counsel. 26 USC 38 – General Business Credit
8
Internal Revenue Service. Guidance on Amortization of Specified Research or Experimental Expenditures Under Section 174
9
Internal Revenue Service. Instructions for Schedule UTP (Form 1120)
10
Internal Revenue Service. Instructions for Form 6765 (12/2025)